CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -35.7% | 7,500 | 0.0% | 0.01% | -33.3% |
| Q2 2022 | $14,000 | -6.7% | 7,500 | 0.0% | 0.02% | +7.1% |
| Q1 2022 | $15,000 | -25.0% | 7,500 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $20,000 | -58.3% | 7,500 | -29.9% | 0.02% | -59.0% |
| Q3 2021 | $48,000 | +84.6% | 10,700 | +137.8% | 0.04% | +95.0% |
| Q2 2010 | $26,000 | – | 4,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |